Virus News and Research

Latest Virus News and Research

Low-income black households disproportionately affected by Covid-19 shutdowns

The alarming rate at which Covid-19 has killed Black Americans has highlighted the deeply embedded racial disparities in the U.S. health care system.

30 Nov 2020

Infection control, widespread testing help reduce SARS-CoV-2 transmission in schools, study finds

Now, a team of researchers at the New York University Grossman School of Medicine explored which school policies had the most significant impact on reducing the risk of in-school SARS-CoV-2 transmission.

30 Nov 2020

Researchers reveal how SARS-CoV-2 reaches the brain

Using post-mortem tissue samples, a team of researchers from Charité - Universitätsmedizin Berlin have studied the mechanisms by which the novel coronavirus can reach the brains of patients with COVID-19, and how the immune system responds to the virus once it does.

30 Nov 2020

Chemical compounds in foods can block the function of key SARS-CoV-2 enzyme

Chemical compounds in foods or beverages like green tea, muscadine grapes and dark chocolate can bind to and block the function of a particular enzyme, or protease, in the SARS-CoV-2 virus, according to a new study by plant biologists at North Carolina State University.

30 Nov 2020

Memory B cells persist in recovered COVID-19 patients

A team of scientists from the University of Washington, USA, and the Karolinska Institute, Sweden, has comprehensively studied the antibody-mediated immune responses in patients diagnosed with coronavirus disease 2019 (COVID-19).

30 Nov 2020

Wyss Institute’s eRapid technology licensed to The iQ Group Global

Today, the Wyss Institute for Biologically Inspired Engineering at Harvard University announced that its eRapid technology has been licensed to The iQ Group Global for COVID-19 diagnostic applications.

30 Nov 2020

New effort to increase COVID-19 testing in Louisiana's Black communities

Pennington Biomedical Research Center is leading a federally funded effort to increase COVID-19 testing in Louisiana's Black communities, which have been hit hard by the virus.

30 Nov 2020

Experimental vaccine protects cynomolgus macaques against Crimean-Congo hemorrhagic fever virus

An experimental vaccine developed in Europe to prevent infection by Crimean-Congo hemorrhagic fever virus (CCHFV) has protected cynomolgus macaques in a new collaborative study from National Institutes of Health scientists.

30 Nov 2020

A mutant SARS-CoV-2 subspecies from minks may evade antibody detection

In a recent research letter published on the bioRxiv preprint server, scientists from Japan discovered that the mutation of spike glycoprotein in the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) derived from farmed minks can also be found in the group of individuals with coronavirus disease (COVID-19) and subsequently evade detection by our immune system.

30 Nov 2020

Rutgers leading a clinical trial assessing combination treatment for coronavirus

Rutgers is leading a clinical trial assessing the combination of nitazoxanide, ribavirin and hydroxychloroquine to treat people 21 or older who are infected with SARS-CoV-2 and are asymptomatic or mildly symptomatic.

30 Nov 2020

Virus induced lymphocytes show promise for COVID-19 and future pandemics

Researchers in the United States have conducted a study demonstrating the potential of a novel therapeutic approach to treating coronavirus disease 2019 (COVID-19). The therapy augments the body’s T cell response to the causative agent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by providing a boost of rapidly expanded virus-specific T cells.

30 Nov 2020

Highly functional immune response in asymptomatic SARS-CoV-2 infection

Researchers in Singapore have conducted a study showing that asymptomatic individuals infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19) – mount an efficient, balanced and coordinated cellular immune response that protects the host without appearing to trigger any pathological processes.

30 Nov 2020

Study: More than one-third of children with COVID-19 are asymptomatic

More than one-third of kids who have COVID-19 are asymptomatic, according to a University of Alberta study that suggests youngsters diagnosed with the disease may represent just a fraction of those infected.

30 Nov 2020

UC San Diego chosen to lead an international $28-million grant for HIV/AIDS clinical trials

University of California San Diego Collaborative Clinical Trials Unit has been selected by the National Institutes of Health to lead and administer an international seven-year, $28-million grant for science-driven clinical trials that deliver innovative, efficient results needed to turn the corner on the HIV/AIDS pandemic.

30 Nov 2020

Mollusc-derived compounds potential medicines for COVID-19 and other respiratory diseases

A research team has reviewed the existing literature on compounds derived from molluscs used for treating respiratory diseases.

30 Nov 2020

Transmission 'hot zones' drive COVID-19 infection patterns, says study

A recent study describes two different mathematical models of high infection zones, which lead to different effects on viral transmission. This underlines the need to understand how the virus spreads within a community as well as within subgroups with different patterns of interaction.

30 Nov 2020

Severe COVID-19 can produce high long-term neutralizing antibodies, study finds

A new study published by a team of scientists in Spain indicates that neutralizing immunity can last for up to 8 months, despite a steep drop in antibody titer over this time.

30 Nov 2020

Are SARS-CoV-2 protease inhibitors effective antivirals in treating COVID-19?

Many antiviral development studies have focused on the possibility of inhibiting the main viral protease (Mpro), and papain-like protease (PLpro), given their central role in viral replication. A new study draws attention to the high odds that these may not have anti-infective activity because of the redundant pathways present in human host cells.

30 Nov 2020

UK’s post-lockdown COVID-19 restrictions allows families to celebrate Christmas 2020 together

The UK's three-tier system of COVID-19 restrictions could be tweaked to allow a more effective control of viral spread, while still ensuring that families can choose their own course of action over the Christmas holidays, says a new preprint published on the medRxiv* server in late November 2020.

30 Nov 2020

Excessive use of antibiotics during COVID-19 pandemic could intensify drug resistance

A new study published in the journal Science of The Total Environment in November 2020 discusses this potentially serious issue along with its wider consequences.

30 Nov 2020

Virus News and Research

Latest Virus News and Research

Low-income black households disproportionately affected by Covid-19 shutdowns

Infection control, widespread testing help reduce SARS-CoV-2 transmission in schools, study finds

Researchers reveal how SARS-CoV-2 reaches the brain

Chemical compounds in foods can block the function of key SARS-CoV-2 enzyme

Memory B cells persist in recovered COVID-19 patients

Wyss Institute’s eRapid technology licensed to The iQ Group Global

New effort to increase COVID-19 testing in Louisiana's Black communities

Experimental vaccine protects cynomolgus macaques against Crimean-Congo hemorrhagic fever virus

A mutant SARS-CoV-2 subspecies from minks may evade antibody detection

Rutgers leading a clinical trial assessing combination treatment for coronavirus

Virus induced lymphocytes show promise for COVID-19 and future pandemics

Highly functional immune response in asymptomatic SARS-CoV-2 infection

Study: More than one-third of children with COVID-19 are asymptomatic

UC San Diego chosen to lead an international $28-million grant for HIV/AIDS clinical trials

Mollusc-derived compounds potential medicines for COVID-19 and other respiratory diseases

Transmission 'hot zones' drive COVID-19 infection patterns, says study

Severe COVID-19 can produce high long-term neutralizing antibodies, study finds

Are SARS-CoV-2 protease inhibitors effective antivirals in treating COVID-19?

UK’s post-lockdown COVID-19 restrictions allows families to celebrate Christmas 2020 together

Excessive use of antibiotics during COVID-19 pandemic could intensify drug resistance

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Virus News and Research

Latest Virus News and Research

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in